BridgeMD
New treatment option for Benzodiazepines
Official title Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
ClinicalTrials.gov ID: NCT04532606
What this study is testing
What is Remimazolam?
Remimazolam is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for benzodiazepines.
Also referred to as Remimazolam anesthesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Bladder cancer is one of the most common genitourinary cancers. Transurethral resection of bladder tumor (TURBT) is the standard therapy for nonmuscle invasive bladder cancer.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 90
You may be able to join if
- Age ≥50 years and \<90 years;
- Preoperative diagnosis is non-muscle-invasive bladder cancer(Ta-T1);
- Scheduled to undergo transurethral resection of bladder tumor;
- Agree to participate, and provide written informed consent.
You likely can't join if
- Refuse to participate;
- Emergent surgery;
- Combined with other malignant tumors;
- Use of benzodiazepines for 1 week within the last month before surgery;
- Preoperative history of schizophrenia, epilepsy, parkinsonism or myasthenia gravis;
- Inability to communicate in the preoperative period due to coma, profound dementia, language barrier, or end-stage disease;
See the full eligibility criteria
- Age ≥50 years and \<90 years;
- Preoperative diagnosis is non-muscle-invasive bladder cancer(Ta-T1);
- Scheduled to undergo transurethral resection of bladder tumor;
- Agree to participate, and provide written informed consent.
- Refuse to participate;
- Emergent surgery;
- Combined with other malignant tumors;
- Use of benzodiazepines for 1 week within the last month before surgery;
- Preoperative history of schizophrenia, epilepsy, parkinsonism or myasthenia gravis;
- Inability to communicate in the preoperative period due to coma, profound dementia, language barrier, or end-stage disease;
- Critical illness (preoperative American Society of Anesthesiologists physical status classification ≥IV), severe hepatic dysfunction (Child-Pugh class C), or severe renal dysfunction (undergoing dialysis before surgery);
- The purpose of surgery is to make a diagnosis or preoperative judgement is that tumor cannot be completely removed.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
- Beijin, Bejing, China
- Guiyang, Guizhou, China
- Nanjing, Jiangsu, China
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China; Beijin, Bejing, China; Guiyang, Guizhou, China; Nanjing, Jiangsu, China; Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.